Cargando…

Insurance Implications for Individuals with a High Risk of Breast and Ovarian Cancer in Europe

Detalles Bibliográficos
Autores principales:	Morrison, P. J., Steel, C. M., Vasen, H. F. A., Eccles, D., Evans, D. G. R., Møller, P., Hodgson, S., Stoppa-Lyonnet, D., Chang-Claude, J., Caligo, M., Olah, E., Haites, N. E., Nevin, N. C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 1999
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851117/ https://www.ncbi.nlm.nih.gov/pubmed/10595272 http://dx.doi.org/10.1155/1999/748254

Ejemplares similares

Cancer Genetics Services in Europe
por: Hodgson, S., et al.
Publicado: (1999)

Genetic Testing for Breast Cancer Predisposition in 1999: Which Molecular Strategy and which Family Criteria?
por: Stoppa-Lyonnet, D., et al.
Publicado: (1999)

Current Policies for Surveillance and Management in Women at Risk for Breast and Ovarian Cancer: A Survey among 16 European Family Cancer Clinics
por: Vasen, H. F. A., et al.
Publicado: (1999)

Ethical, Social and Economic Issues in Familial Breast Cancer: A Compilation of Views from the E.C. Biomed II Demonstration Project
por: Steel, Michael, et al.
Publicado: (1999)

Utilisation of Prophylactic Mastectomy in 10 European Centres
por: Evans, D. G. R., et al.
Publicado: (1999)

Guidelines for Follow-Up of Women at High Risk for Inherited Breast Cancer: Consensus Statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer
por: Møller, P., et al.
Publicado: (1999)

Risk Estimation as a Decision-Making Tool for Genetic Analysis of the Breast Cancer Susceptibility Genes
por: Chang-Claude, Jenny, et al.
Publicado: (1999)

Mutation-Specific Survival of Inherited Breast Cancer
por: Møller, P., et al.
Publicado: (1999)

Screening of male breast cancer and of breast-ovarian cancer families for BRCA2 mutations using large bifluorescent amplicons
por: Pages, S, et al.
Publicado: (2001)

Management of Hereditary Breast Cancer
por: Eccles, D. M., et al.
Publicado: (1999)

Efficacy of Early Diagnosis and Treatment in Women with a Family History of Breast Cancer
por: Møller, Pål, et al.
Publicado: (1999)

The biological effects and clinical implications of BRCA mutations: where do we go from here?
por: Stoppa-Lyonnet, Dominique
Publicado: (2016)

An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study
por: Li, K, et al.
Publicado: (2015)

Cellular responses to ionising radiation of AT heterozygotes: differences between missense and truncating mutation carriers
por: Fernet, M, et al.
Publicado: (2004)

Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma.
por: Eccles, D. M., et al.
Publicado: (1992)

Sickness Insurance in Central Europe and its Lessons for us in the United States
por: Winslow, C.-E. A.
Publicado: (1929)

Increased risk of breast cancer among female relatives of patients with ataxia-telangiectasia: a causal relationship?
por: d'Almeida, A K, et al.
Publicado: (2005)

Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer
por: McFadyen, M C E, et al.
Publicado: (2001)

Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort
por: Watson, M, et al.
Publicado: (2004)

P53 mutations in breast and ovarian carcinomas from BRCA1 and 2 mutation carriers and noncarriers
por: Sensi, E, et al.
Publicado: (2000)

Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16(INK4A), P14(ARF) or cdk4 genes
por: Soufir, N, et al.
Publicado: (2000)

Editorial
por: Haites, Neva, et al.
Publicado: (1999)

Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours.
por: Gabra, H., et al.
Publicado: (1995)

Non-Coding Variants in BRCA1 and BRCA2 Genes: Potential Impact on Breast and Ovarian Cancer Predisposition
por: Santana dos Santos, Elizabeth, et al.
Publicado: (2018)

A Second Family with Probable CRAC (Colorectal Adenomata and Carcinoma) Syndrome—A New Familial Cancer
por: Morrison, P. J., et al.
Publicado: (1999)

Nursing for the Insured
por: Hodgson, W. Gill
Publicado: (1922)

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
por: Antoniou, A C, et al.
Publicado: (2008)

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
por: Antoniou, A C, et al.
Publicado: (2008)

Huntington disease in County Donegal: epidemiological trends over four decades.
por: Morrison, P. J., et al.
Publicado: (1993)

Cancer Genetics Services in Northern Ireland
por: Morrison, P. J., et al.
Publicado: (1999)

Germline mutations of BRCA1-associated RING domain (BARD1) gene in breast and/or ovarian families negative for BRCA1 and 2 alterations
por: Ghimenti, C, et al.
Publicado: (2000)

Insurability of HIV-positive people treated with antiretroviral therapy in Europe: collaborative analysis of HIV cohort studies
por: Kaulich-Bartz, Josee, et al.
Publicado: (2013)

Molecular Cancer Genetics in Eastern and Central Europe
por: Olah, Edith
Publicado: (1999)

Familial craniosynostosis due to Pro250Arg mutation in the fibroblast growth factor receptor 3 gene.
por: Hughes, J., et al.
Publicado: (2001)

Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families
por: Janin, N, et al.
Publicado: (1999)

Mutation Analysis of BRCA1 and BRCA2 in Italian Hereditary and Sporadic Forms of Breast and Ovarian Cancers: Tumor Genotype-Phenotype Correlation in Breast Cancer BRCA-Mutation Carriers
por: Cipollini, G., et al.
Publicado: (1999)

p53 mutation and expression in lymphoma.
por: Adamson, D. J., et al.
Publicado: (1995)

How is enrollees’ trust in health insurers associated with choosing health insurance?
por: van der Hulst, Frank J. P., et al.
Publicado: (2023)

Advice from the health insurer as a channelling strategy: a natural experiment at a Dutch health insurance company
por: Bes, Romy E., et al.
Publicado: (2018)

Low expression of bcl-2 in Brca1-associated breast cancers
por: Freneaux, P, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_rbs2o2gs52uajqhb9qeu41gtv3